ROSETTA INPHARMATICS
ROSETTA INPHARMATICS
Industry:
Biotechnology Health Care Medical
Founded:
1996-01-01
Address:
Kirkland, Washington, United States
Country:
United States
Status:
Active
Contact:
(425)820-8900
Similar Organizations
Founder
More informations about "Rosetta Inpharmatics"
Rosetta Inpharmatics Company Profile 2024: Valuation, Investors ...
Information on acquisition, funding, investors, and executives for Rosetta Inpharmatics. Use the PitchBook Platform to explore the full profile. Request a free trial Log inSee details»
Rosetta Inpharmatics - Crunchbase Company Profile & Funding
Rosetta Inpharmatics is located in Kirkland, Washington, United States. Who are Rosetta Inpharmatics's competitors? Alternatives and possible competitors to Rosetta Inpharmatics …See details»
Rosetta Inpharmatics - Products, Competitors, Financials, …
Rosetta Inpharmatics, a wholly owned subsidiary of Merck and Co. Inc., develops and implements technologies that will improve drug discovery. Loading... Rosetta Inpharmatics has filed 4 …See details»
Merck Acquires Rosetta Inpharmatics | Mergr M&A Deal Summary
May 11, 2001 · Rosetta Inpharmatics, Inc. is a developer of new technologies for drug discovery that allow high-throughput screening of potential therapeutic compounds for their effects on cells.See details»
Rosetta Inpharmatics LLC - Company Profile and News
Rosetta Inpharmatics LLC is involved in the field of informational genomics. The Company manufactures equipment and software for use analyzing genetic information to identify gene...See details»
Merck Buys Rosetta For $620 Million - Forbes
May 11, 2001 · Merck is buying Rosetta Inpharmatics for $620 million in a tax-free, all-stock deal, paying an 80% premium to fold the Kirkland, Wash.-based biotech into its own research labs. …See details»
Stratagene and Merck Subsidiary, Rosetta Inpharmatics, enter into …
Aug 16, 2006 · Stratagene Corporation has entered into a joint development and license agreement with Rosetta Inpharmatics LLC, a wholly-owned subsidiary of Merck & Co., Inc., to …See details»
Rosetta Inpharmatics - Crunchbase
Rosetta Inpharmatics LLC is an informational genomics company.See details»
Microsoft Signs Agreement With Merck & Co., Inc. to Acquire
REDMOND, Wash., June 1 /PRNewswire-FirstCall/ -- Microsoft Corp. today announced that it has signed an agreement with Merck & Co. Inc. to acquire certain assets of Rosetta Biosoftware, a …See details»
Rosetta Inpharmatics - Tech Stack, Apps, Patents & Trademarks
Rosetta Inpharmatics LLC is an informational genomics company.See details»
Industrial-strength profiling: Chemistry & Biology - Cell Press
In its brief history, Rosetta Inpharmatics, Inc. (Kirkland, WA) has generated a lot of data. Data from 25 000 whole genome array scans, for starters. The company believes that the sheer …See details»
Stephen Friend | Nature Reviews Drug Discovery
What led to the creation of Rosetta Inpharmatics? Rosetta Inpharmatics grew out of an incubator at the Fred Hutchinson Cancer Center, funded by the government through the National...See details»
Rosetta Inpharmatics CEO, Founder, Key Executive Team, Board of ...
Rosetta Inpharmatics has 6 executives. Rosetta Inpharmatics's current Senior Vice President is Mark Boguski. You're one click away from the most comprehensive, unmatched analyst …See details»
Biotech Briefing: Rosetta Inpharmatics - Forbes
Nov 9, 2000 · Rosetta has developed a patented software platform, the Rosetta Resolver, that uses pattern-recognition technology to sort through the mountains of genetic data developed …See details»
Stephen Friend - Wikipedia
Formerly Senior Vice-president at Merck & Co. Friend co-founded Rosetta Inpharmatics with Leland H. Hartwell and Leroy Hood in 1996. [4] . Much of his research has focused on cancer. …See details»
PacBio Hires Rosetta Inpharmatics' Eric Schadt as CSO; Will
May 28, 2009 · Pacific Biosciences said last week that it has hired Eric Schadt as chief scientific officer — a new position for the firm.See details»
Rosetta lnpharmatics chips in - Nature
Rosetta Inpharmatics, a newly founded com pany in Kirkland, WA, raised $17.5 million in September. The company plans to develop "third- or fourth-generation biochips" aimed initially …See details»
Integrating large-scale functional genomic data to dissect the ...
Jun 15, 2008 · Integrating large-scale functional genomic data to dissect the complexity of yeast regulatory networks. 1. Rosetta Inpharmatics, LLC, Seattle, Washington 98109, USA. A key …See details»
People - Sage Bionetworks
Dr. Schadt was a founding member of Sage Bionetworks, Chief Scientific Officer at Pacific Biosciences, and Executive Director of Genetics and Chief Scientist at Rosetta …See details»
Phase I/II trial of vorinostat combined with temozolomide and …
Aug 22, 2017 · These signatures were developed by Rosetta Inpharmatics, using mRNA gene expression data from a panel of >200 tumor cell lines that were either sensitive to vorinostat …See details»